Safetek International Inc., Matrix Advanced Solutions deal

Matrix's Matrix Pharma Inc. subsidiary granted Safetek an option to acquire exlusive worldwide rights to oral thrombin inhibitors. The cardiovascular compounds are in lead optimization. Matrix is elig...